Table 3.
Percentage of lymphocytes by immunophenotype
| CD antigen | No. in each group | Study group % | Control group % | P-value | |
|---|---|---|---|---|---|
| CD3+ | 19 | 59·26 ± 9·85 | 66·74 ± 9·49 | 0·02 | |
| CD3+ CD4+ | 19 | 30·14 ± 10·26 | 36·55 ± 8·87 | 0·05 | |
| CD3+ CD8+ | 19 | 26·70 ± 8·66 | 29·47 ± 6·05 | 0·26 | |
| CD19+ | 18 | 15·27 ± 10·35 | 11·68 ± 5·20 | 0·12 | |
| CD3+ CD45RO+ | 19 | 29·86 ± 9·47 | 28·87 ± 10·79 | 0·76 | |
| CD3+ CD45RA+ | 19 | 42·39 ± 13·85 | 51·13 ± 13·59 | 0·06 | |
| CD16+ CD56+ | 10 | 12·75 ± 5·10 | 9·17 ± 3·14 | 0·09 | |
| CD8+ CD62L+ CD103+ | 10 | 4·37 ± 10·26 | 1·26 ± 0·41 | 0·37 | |
| Small CD8+ CD62L+ CD103+ | 10 | 20·20 ± 12·88 | 12·89 ± 9·66 | 0·19 | |
| CD3+ CD103+ | 9 | 1·03 ± 0·39 | 1·34 ± 0·53 | 0·18 | |
| CD3+ TCRγδ+ | 19 | 2·75 ± 1·51 | 3·65 ± 2·46 | 0·18 |
All data given as average ± s.d.